{"entity":{"id":"nct06810375","kind":"trial","name":"Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery","aka":[],"tldr":"A phase 3 trial in lung cancer, run by George Washington University, now recruiting.","summary":"Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery is a phase 3, randomised interventional study registered as NCT06810375 by George Washington University, with a registry enrolment figure of 120 participants, started 2025-03-01 and due to reach its primary completion in 2028-02-28. Interventions recorded: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®); Intercostal nerve block. Conditions listed: Lung Cancers. Primary outcome: Postoperative pain control assessment; Morphine equivalent assessment. Sites: United States. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT06810375","url":"https://clinicaltrials.gov/study/NCT06810375"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["lung-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06810375","phase":"3","setting":"Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery","sponsor":"George Washington University","enrolled":120,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06810375/","neighbours":{"cancer":[{"id":"lung-cancer","kind":"cancer","name":"Lung cancer (all types)","route":"/cancers/lung-cancer/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}